Philips delivers Q4 sales of EUR 6 billion, with 3% comparable sales growth; income from continuing operations amounted to EUR 550 million and Adjusted EBITA margin increased to 17.9% Fourth-quarter highlights Sales amounted to EUR 6 billion, with 3% comparable sales growth Comparable order intake increased 3% Income from continuing […]
Author: Ken Dropiewski
Merit Medical Issues Statement Regarding Director Nominations From Starboard
SOUTH JORDAN, Utah, Jan. 27, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today confirmed that it has received notice from Starboard Value […]
CorMatrix® Cardiovascular, Inc. announces the first minimally invasive robotic implant of Cor® PATCH for epicardial support and repair
ATLANTA, Jan. 28, 2020 /PRNewswire/ — CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announces the first minimally invasive robotic implant of Cor® PATCH by Dr. Husam H. Balkhy, Professor of Surgery, and Director of Robotic and Minimally Invasive Cardiac Surgery at the University of Chicago Medicine. Dr. Balkhy is a global leader […]
Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance
PARIS and NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC, OTCQX – QNNTF), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure, today announced the appointment of Benoît Gueugnon as Vice-President […]
Neovasc Announces Executive Steering Committee for Transfemoral Trans-septal Tiara Program
VANCOUVER, Jan. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today the Executive Steering Committee for […]
Amol Soin, MD, One Of The Nation’s Leading Pain Experts, Named As JanOne’s Chief Medical Officer
Soin brings extensive pain treatment and clinical experience to the JanOne team with particular expertise in pain associated with cardiovascular conditions LAS VEGAS, Jan. 28, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with nonaddictive […]
Inari Medical Appoints Cynthia Lucchese and Catherine Szyman to the Company’s Board of Directors
IRVINE, Calif., Jan. 28, 2020 /PRNewswire/ — Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese and Catherine Szyman to the company’s Board of Directors. “We are pleased to welcome Cindy and Katie as new […]
UPDATE: Desert Medical Imaging, ProScan Imaging & Chico Breast Care Center Join Forces with HALO Diagnostics (HALO Dx)
Desert Medical Imaging to become HALO Dx Center of Innovation MENLO PARK, Calif., Jan. 30, 2020 /PRNewswire/ — HALO Dx, Inc., a rapid growth technology company headquartered in Silicon Valley, has brought together top technology experts with leading radiologists to set the new standard of care for the industry. By leveraging leading-edge artificial […]
Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities
NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 28, 2020 /PRNewswire/ – Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), (“Correvio” or the “Company”) announced today that it has received two written notifications from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price and the minimum market […]
DalCor announces dal-GenE trial to continue as planned following interim futility analysis
LONDON and MONTREAL, Jan. 27, 2020 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced that following the results of the interim futility analysis of the dalcetrapib dal-GenE Phase 3 trial, DalCor will continue the dal-GenE trial as recommended by the independent Data and Safety Monitoring Board (DSMB). “We are pleased to […]



